Teva announces agreement to divest teva-takeda, its business venture in japan

Tel aviv, israel, dec. 05, 2024 (globe newswire) -- today, teva pharmaceutical industries ltd. (nyse and tase: teva) announced that it has entered into an agreement with jki, established by the fund managed and operated by j-will, whereby all shares of teva takeda pharma limited and its wholly owned subsidiary teva takeda yakuhin ltd. will be transferred to jki.
TEVA Ratings Summary
TEVA Quant Ranking